CAFs can promote migration and invasiveness in breast cancer cells, as well as in the EMT, by secreting CTHRC1 [119], with the PI3K pathway being one of the potential driving signaling pathways for CTHRC1 [120]. Here, CTHRC1 is linked to breast carcinoma.